Bascom Palmer Eye Institute VisionGen Initiative supports researchers studying the genetics and epigenetics of inherited eye diseases and ocular cancer to improve screening, prevention, and treatment.
Addendum 2, dated November 10, 2026, has been added to the funding announcement.
Funder: Florida Department of Health
Due Dates (Anticipated): November 2027 (Application deadline)
Funding Amounts: Category maximums of $100,000–$1,500,000, including direct and indirect costs, for 6–48 months
Summary: Competitive grants advance genetic and epigenetic research on inherited eye diseases and ocular cancer.
Key Information: Applicants must be Florida-based universities or established research institutes, with a U.S. citizen or permanent resident PI.
The Bascom Palmer Eye Institute VisionGen Initiative supports genetic and epigenetic research on inherited eye diseases and ocular cancer through competitive, peer-reviewed grants. Established under section 381.922, Florida Statutes, the initiative is administered by the Florida Department of Health’s Biomedical Research Section, with advice from the Biomedical Research Advisory Council (BRAC).
Supported work spans prevention and treatment, screening, obesity, treatment-related morbidities, technology-transfer feasibility, and development of Investigational New Drug or Investigational Device Exemption applications. Priorities include reducing morbidity and mortality, improving screening accuracy and detection, addressing resistance to front-line treatments in recurrent disease, and understanding obesity’s relationship to disease, treatment responsiveness, and treatment-related morbidities. Ocular cancer research must align with the Florida Cancer Plan.